John Murphy

John Murphy leads the legal and policy functions, both domestic and international, for all healthcare, agricultural, and environmental biotechnology advocacy across the organization. BIO's policy and advocacy centers on developing and implementing legislative, regulatory, and international policies that foster a robust ecosystem for novel biotechnology development throughout the world. Biotech innovation focuses on the development of first-in-kind medicines to treat unmet medical needs, new climate technologies to address global climate change issues, and groundbreaking agricultural developments that seek to strengthen and expand the global food supply.

Additionally, Mr. Murphy manages the legal functions of the organization's healthcare division. This role encompasses all legal issues impacting healthcare biotechnology across the country, with responsibilities including oversight of Congressional legislation, FDA and CMS regulatory issues, litigation, and support of state-developed biotechnology laws and regulations.

Mr. Murphy is a frequent speaker on issues associated with patient access to prescription medicines, prescription drug abuse, drug pricing, and more general issues impacting medicine approvals, regulation, and innovation in the US and abroad.